المؤلفون: Propel, Investigators, Thommes, J, Najera, I, Chen, Yc, Munson, Ml, Ipe, D, Vierling, J, Pockros, P, Bzowej, N, Rodriguez Torres, M, Zeuzem, S, Mm, Ma, Ferenci, P, Herring, R, Jensen, D, Wedemeyer, H, Agarwal, K, Andreone, P, Benhamou, Y, Berg, T, Bloomer, J, Bronowicki, J, Brunetto, MAURIZIA ROSSANA, Bruno, S, Calleja, Jl, Iglesias, Ma, Cheng, W, Ciancio, A, Clark, V, Crawford, D, de Lédinghen, V, Desmond, P, Diago, M, Dikopoulos, N, Freilich, B, Godofsky, E, Hassanein, T, Hézode, C, Jacobson, I, Klass, Dm, Kuo, A, Lee, Ss, Leggett, B, Macdonald, Ga, Mac Quillan, G, Marotta, P, Vila, R, Pol, S, Ramji, A, Rasenack, Jw, Ratziu, V, Roberts, S, Romero Gómez, M, Rosenberg, W, Rossaro, L, Salmeron, Fj, Sánchez Tapias, Jm, Sanyal, Aj, Scuteri, A, Sepe, T, Sheikh, A, Sherman, M, Simon, Gl, Slim, J, Smith, Jp, Solà, R, Strasser, Si, Strohecker, J, Sulkowski, M, Tran, A, Willems, B, Yoshida, E, Zachoval, R, Zarski, J. .

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Cirrhosis, Adolescent, Genotype, Hepatitis C virus, Hepacivirus, medicine.disease_cause, Placebo, Gastroenterology, Deoxycytidine, law.invention, Polyethylene Glycols, chemistry.chemical_compound, Young Adult, Randomized controlled trial, Double-Blind Method, law, Pegylated interferon, Internal medicine, Ribavirin, medicine, Humans, Aged, Hepatology, Dose-Response Relationship, Drug, business.industry, Interleukins, virus diseases, Interferon-alpha, Hepatitis C, Chronic, Middle Aged, medicine.disease, digestive system diseases, Recombinant Proteins, Surgery, Treatment Outcome, chemistry, RNA, Viral, Drug Therapy, Combination, Female, Interferons, business, Mericitabine, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e520e34f9e35bb4e185dc082ad781d46
http://hdl.handle.net/2318/145343

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Vega DM; Friends of Cancer Research, Washington, DC., Nishimura KK; Cancer Research And Biostatistics (CRAB), Seattle, WA., Zariffa N; NMD Group LLC, Bala Cynwyd, PA., Thompson JC; Division of Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Hoering A; Cancer Research And Biostatistics (CRAB), Seattle, WA., Cilento V; Cancer Research And Biostatistics (CRAB), Seattle, WA., Rosenthal A; Cancer Research And Biostatistics (CRAB), Seattle, WA., Anagnostou V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Baden J; Translational Medicine, Bristol Myers Squibb, Princeton, NJ., Beaver JA; Oncology Center of Excellence, Food and Drug Administration (FDA), Silver Spring, MD., Chaudhuri AA; Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO.; Department of Genetics, Washington University School of Medicine, St Louis, MO.; Department of Computer Science and Engineering, Washington University, St Louis, MO.; Siteman Cancer Center, Washington University School of Medicine, St Louis, MO., Chudova D; Guardant Health Inc, Redwood City, CA., Fine AD; Research and Development, Foundation Medicine Inc, Cambridge, MA., Fiore J; Oncology Development, Bristol Myers Squibb, Princeton, NJ., Hodge R; Late Oncology Statistics, Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom., Hodgson D; Translational Medicine, Oncology Research & Development, AstraZeneca, Waltham, MA., Hunkapiller N; GRAIL, Menlo Park, CA.; During the conduct of this work and development of the manuscript, N.H. was affiliated with GRAIL, Inc; however, is not affiliated with GRAIL, Inc at the time of submission., Klass DM; Assay Development, Roche Sequencing Solutions, Pleasanton, CA., Kobie J; Translational Oncology, Early Oncology Statistics, Merck Research Laboratories, Kenilworth, NJ., Peña C; Companion Diagnostics, Oncology Early Development, Merck Research Laboratories, Kenilworth, NJ., Pennello G; Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Food and Drug Administration (FDA), Silver Spring, MD., Peterman N; Foundation Medicine Inc, San Diego, CA., Philip R; Division of Molecular Genetics, Office of Health Technology 7 (In Vitro Diagnostics and Radiological Health), Food and Drug Administration (FDA), Silver Spring, MD., Quinn KJ; Guardant Health Inc, Redwood City, CA., Raben D; Product Development Oncology, Genentech Inc, South San Francisco, CA., Rosner GL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Sausen M; Translational Medicine, Bristol Myers Squibb, Princeton, NJ., Tezcan A; Foundation Medicine Inc, San Diego, CA., Xia Q; Product Development Data Sciences, Genentech Inc, South San Francisco, CA., Yi J; Product Development Oncology, Genentech Inc, South San Francisco, CA., Young AG; Research and Development, Foundation Medicine Inc, Cambridge, MA., Stewart MD; Friends of Cancer Research, Washington, DC., Carpenter EL; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Aggarwal C; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Allen J; Friends of Cancer Research, Washington, DC.

المصدر: JCO precision oncology [JCO Precis Oncol] 2022 Aug; Vol. 6, pp. e2100372.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Circulating Tumor DNA*/genetics , Lung Neoplasms*/drug therapy, Biomarkers, Tumor/genetics ; Clinical Trials as Topic ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Prognosis

المؤلفون: Saelee SL; Roche Sequencing Solutions, Inc., Pleasanton, California., Lovejoy AF; Roche Sequencing Solutions, Inc., Pleasanton, California., Hinzmann B; Roche Sequencing Solutions, Inc., Potsdam, Germany., Mayol K; Roche Sequencing Solutions, Inc., Pleasanton, California., Huynh S; Roche Sequencing Solutions, Inc., Pleasanton, California., Harrell A; Roche Sequencing Solutions, Inc., Pleasanton, California., Lefkowitz J; Roche Sequencing Solutions, Inc., Pleasanton, California., Deodhar N; Roche Sequencing Solutions, Inc., Pleasanton, California., Garcia-Montoya G; Roche Sequencing Solutions, Inc., Pleasanton, California., Yaung SJ; Roche Sequencing Solutions, Inc., Pleasanton, California. Electronic address: stephanie.yaung@roche.com., Klass DM; Roche Sequencing Solutions, Inc., Pleasanton, California. Electronic address: dan.klass@roche.com.

المصدر: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2022 Jun; Vol. 24 (6), pp. 566-575. Date of Electronic Publication: 2022 Mar 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE

مواضيع طبية MeSH: Cell-Free Nucleic Acids*/genetics , Circulating Tumor DNA*/genetics, High-Throughput Nucleotide Sequencing/methods ; Humans ; Mutation ; Polymerase Chain Reaction

المؤلفون: Noé J; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Lovejoy A; Roche Sequencing Solutions, Pleasanton, California., Ou SI; University of California, Irvine School of Medicine, Orange, California., Yaung SJ; Roche Sequencing Solutions, Pleasanton, California., Bordogna W; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Klass DM; Roche Sequencing Solutions, Pleasanton, California., Cummings CA; Genentech Inc., South San Francisco, California., Shaw AT; Massachusetts General Hospital, Boston, Massachusetts. Electronic address: ashaw1@mgh.harvard.edu.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2020 Apr; Vol. 15 (4), pp. 601-608. Date of Electronic Publication: 2019 Nov 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Adult ; Anaplastic Lymphoma Kinase/genetics ; Carbazoles/therapeutic use ; Clinical Trials as Topic ; Drug Resistance, Neoplasm/genetics ; Humans ; Mutation ; Piperidines ; Prospective Studies ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use

المؤلفون: Berg T; Section of Hepatology, Clinic for Gastroenterology and Rheumatology, University Clinic Leipzig, Leipzig, Germany. Electronic address: thomas.berg@medizin.uni-leipzig.de., Simon KG; Gastroentrologische Gemeinschaftspraxis, Leverkusen, Germany., Mauss S; Zentrum für HIV und Hepatogastroenterologie, Düsseldorf, Germany., Schott E; Charite Universitätsmedizin, Berlin, Germany., Heyne R; Leberzentrum Checkpoint, Berlin, Germany., Klass DM; Klinikum Lüneburg, Lüneburg, Germany., Eisenbach C; Dept. Gastroenterology, GRN-Klinik Weinheim, Weinheim, Germany., Welzel TM; Klinikum der J.W. Goethe-Universität Frankfurt am Main, Germany., Zachoval R; Klinikum der Ludwig-Maximilians München University, München, Germany., Felten G; Gastroenterologische Gemeinschaftspraxis, Herne, Germany., Schulze-Zur-Wiesch J; Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Cornberg M; Hannover Medical School, Hannover; German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Germany., Op den Brouw ML; Gilead Sciences Europe Ltd., Uxbridge, United Kingdom., Jump B; Gilead Sciences Inc., Foster City, USA., Reiser H; Gilead Sciences Inc., Foster City, USA., Gallo L; Gilead Sciences, Martinsried, Germany., Warger T; Gilead Sciences, Martinsried, Germany., Petersen J; IFI Institute for Interdisciplinary Medicine at the Asklepios Klinik St. George, University of Hamburg, Hamburg, Germany.

مؤلفون مشاركون: FINITE CHB study investigators First investigation in stopping TDF treatment after long-term virological suppression in HBeAg-negative chronic hepatitis B]

المصدر: Journal of hepatology [J Hepatol] 2017 Nov; Vol. 67 (5), pp. 918-924. Date of Electronic Publication: 2017 Jul 21.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis B virus*/drug effects , Hepatitis B virus*/genetics , Hepatitis B, Chronic*/diagnosis , Hepatitis B, Chronic*/drug therapy , Hepatitis B, Chronic*/immunology , Hepatitis B, Chronic*/virology , Tenofovir*/administration & dosage , Tenofovir*/adverse effects , Viral Load*/drug effects , Viral Load*/methods, Hepatitis B e Antigens/*immunology , Withholding Treatment/*statistics & numerical data, Adult ; Aftercare/methods ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; DNA, Viral/analysis ; Drug Monitoring/methods ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome

المؤلفون: Scherer F; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Kurtz DM; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.; Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Newman AM; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA., Stehr H; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA., Craig AF; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Esfahani MS; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Lovejoy AF; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA., Chabon JJ; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA., Klass DM; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA., Liu CL; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA., Zhou L; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA., Glover C; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Visser BC; Division of Surgical Oncology, Department of Surgery, Stanford University, Stanford, CA 94305, USA., Poultsides GA; Division of Surgical Oncology, Department of Surgery, Stanford University, Stanford, CA 94305, USA., Advani RH; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Maeda LS; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Gupta NK; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Levy R; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Ohgami RS; Department of Pathology, Stanford University, Stanford, CA 94305, USA., Kunder CA; Department of Pathology, Stanford University, Stanford, CA 94305, USA., Diehn M; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA. arasha@stanford.edu diehn@stanford.edu.; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA., Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA. arasha@stanford.edu diehn@stanford.edu.; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA.

المصدر: Science translational medicine [Sci Transl Med] 2016 Nov 09; Vol. 8 (364), pp. 364ra155.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Circulating Tumor DNA/*genetics , Lymphoma, B-Cell/*genetics , Lymphoma, Large B-Cell, Diffuse/*genetics, Adult ; Aged ; Aged, 80 and over ; Algorithms ; Biomarkers, Tumor/blood ; Biopsy ; Cell-Free System ; Female ; Genotype ; Humans ; Immunoglobulins/chemistry ; Lymphoma, B-Cell/blood ; Lymphoma, Large B-Cell, Diffuse/blood ; Male ; Middle Aged ; Mutation ; Prognosis ; Recurrence ; Treatment Outcome